1 |
Betaferon |
- |
- |
- |
- |
013 1件: 13 💬 |
2 |
Betaferon 250 mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
3 |
Betaferon 250 microgram/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
4 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection |
- |
- |
- |
- |
013 1件: 13 💬 |
5 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection. |
- |
- |
- |
- |
013 1件: 13 💬 |
6 |
Betaferon 250 microgramos |
- |
- |
- |
- |
013 1件: 13 💬 |
7 |
Betaferon 250mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
8 |
Betaferon 250µg |
- |
- |
- |
- |
013 1件: 13 💬 |
9 |
Betaferon 500 mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
10 |
Betaferon 500 µg |
- |
- |
- |
- |
013 1件: 13 💬 |
11 |
Betaferon 500mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
12 |
Betaferon 500µg |
- |
- |
- |
- |
013 1件: 13 💬 |
13 |
Betaferon sc 15f 0,25mg 15sir |
- |
- |
- |
- |
013 1件: 13 💬 |
14 |
Betaferon*15confez 0,25mg/ml+ |
- |
- |
- |
- |
013 1件: 13 💬 |
15 |
Betaferon, bay 86-5046 |
- |
- |
- |
- |
013 1件: 13 💬 |
16 |
Betaferon/betaseron |
- |
- |
- |
- |
013 1件: 13 💬 |
17 |
Betaferon® |
- |
- |
- |
- |
013 1件: 13 💬 |
18 |
Betaferon® (interferon beta-1b) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
19 |
Interferon beta 1-b (betaferon/betaseron, bay86-5046) |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
20 |
Interferon beta-1b (betaferon, bay 86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
21 |
Interferon beta-1b (betaferon, bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
22 |
Interferon beta-1b (betaferon/betaseron, bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
23 |
Interferon beta-1b (betaferon®, bay 86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
24 |
Interferon beta-1b (betaseron, betaferon, bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
25 |
Interferon beta-1b (pf530, betaferon) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |